051910 — LG Chem Balance Sheet
0.000.00%
Last trade - 00:00- KR₩29tn
- KR₩51tn
- KR₩55tn
Annual balance sheet for LG Chem, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,932,025 | 3,906,110 | 3,848,706 | 8,521,497 | 9,283,433 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,935,723 | 5,572,583 | 7,350,184 | 8,136,243 | 8,665,291 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11,869,724 | 16,319,700 | 20,413,820 | 29,674,369 | 28,859,296 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 18,593,642 | 20,567,475 | 24,378,259 | 29,662,743 | 38,950,393 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 34,024,426 | 41,388,894 | 51,135,302 | 67,973,823 | 77,466,694 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8,941,529 | 12,624,219 | 15,062,096 | 16,459,563 | 18,390,839 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 17,019,449 | 23,349,773 | 29,441,518 | 36,523,251 | 45,274,089 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 17,004,977 | 18,039,121 | 21,693,784 | 31,450,572 | 32,192,605 |
| Total Liabilities & Shareholders' Equity | 34,024,426 | 41,388,894 | 51,135,302 | 67,973,823 | 77,466,694 |
| Total Common Shares Outstanding |